OncoImmunology
Volume 2, 2013 - Issue 8
Open access
1,712
Views
4
CrossRef citations to date
0
Altmetric
Author's View
Combination of adoptive cell transfer, anti-PD-L1 and anti-LAG-3 antibodies for the treatment of recurrent tumors
Better with more
Stephen R Goding Department of Pathology; University of Maryland School of Medicine; Baltimore, MD USA
, Kyle A Wilson Department of Microbiology and Immunology; University of Maryland School of Medicine; Baltimore, MD USA
& Paul Andrew Antony Department of Pathology; University of Maryland School of Medicine; Baltimore, MD USA; Department of Microbiology and Immunology; University of Maryland School of Medicine; Baltimore, MD USA; Tumor Immunology and Immunotherapy Program; University of Maryland Cancer Center; Baltimore, MD USACorrespondence[email protected]
Article: e25050
|
Received 15 May 2013, Accepted 15 May 2013, Published online: 20 May 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.